[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market - Global Outlook and Forecast 2021-2027

April 2021 | 92 pages | ID: G0F66D9F6EA5EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) in Global, including the following market information:

Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Segment Percentages, By Type, 2020 (%)
  • Oral
  • Parenteral
China Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Segment Percentages, By Application, 2020 (%)
  • Hospital
  • Clinic
  • Others
Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Pfizer Inc.
  • Alexion Pharmaceuticals Inc.
  • BioMarin Pharmaceutical Inc.
  • Ultragenyx Pharmaceutical Inc.
  • Janssen Pharmaceuticals Inc.
  • Sigma-Tau Pharmaceuticals Inc.
  • AbbVie Inc.
  • Sanofi SA
  • Shire PLC
  • Merck KGaA
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GAUCHER AND POMPE DISEASES ENZYME REPLACEMENT THERAPY (ERT) OVERALL MARKET SIZE

2.1 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size: 2021 VS 2027
2.2 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Players in Global Market
3.2 Top Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Companies Ranked by Revenue
3.3 Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue by Companies
3.4 Top 3 and Top 5 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Companies in Global Market, by Revenue in 2020
3.5 Global Companies Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Players in Global Market
  3.6.1 List of Global Tier 1 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size Markets, 2021 & 2027
  4.1.2 Oral
  4.1.3 Parenteral
4.2 By Type - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue & Forecasts
  4.2.1 By Type - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, 2016-2021
  4.2.2 By Type - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, 2022-2027
  4.2.3 By Type - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2021 & 2027
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue & Forecasts
  5.2.1 By Application - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, 2016-2021
  5.2.2 By Application - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, 2022-2027
  5.2.3 By Application - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2021 & 2027
6.2 By Region - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue & Forecasts
  6.2.1 By Region - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, 2016-2021
  6.2.2 By Region - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, 2022-2027
  6.2.3 By Region - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, 2016-2027
  6.3.2 US Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
  6.3.3 Canada Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
  6.3.4 Mexico Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, 2016-2027
  6.4.2 Germany Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
  6.4.3 France Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
  6.4.4 U.K. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
  6.4.5 Italy Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
  6.4.6 Russia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
  6.4.7 Nordic Countries Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
  6.4.8 Benelux Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, 2016-2027
  6.5.2 China Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
  6.5.3 Japan Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
  6.5.4 South Korea Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
  6.5.5 Southeast Asia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
  6.5.6 India Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, 2016-2027
  6.6.2 Brazil Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
  6.6.3 Argentina Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, 2016-2027
  6.7.2 Turkey Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
  6.7.3 Israel Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
  6.7.4 Saudi Arabia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027
  6.7.5 UAE Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Pfizer Inc.
  7.1.1 Pfizer Inc. Corporate Summary
  7.1.2 Pfizer Inc. Business Overview
  7.1.3 Pfizer Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Major Product Offerings
  7.1.4 Pfizer Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in Global (2016-2021)
  7.1.5 Pfizer Inc. Key News
7.2 Alexion Pharmaceuticals Inc.
  7.2.1 Alexion Pharmaceuticals Inc. Corporate Summary
  7.2.2 Alexion Pharmaceuticals Inc. Business Overview
  7.2.3 Alexion Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Major Product Offerings
  7.2.4 Alexion Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in Global (2016-2021)
  7.2.5 Alexion Pharmaceuticals Inc. Key News
7.3 BioMarin Pharmaceutical Inc.
  7.3.1 BioMarin Pharmaceutical Inc. Corporate Summary
  7.3.2 BioMarin Pharmaceutical Inc. Business Overview
  7.3.3 BioMarin Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Major Product Offerings
  7.3.4 BioMarin Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in Global (2016-2021)
  7.3.5 BioMarin Pharmaceutical Inc. Key News
7.4 Ultragenyx Pharmaceutical Inc.
  7.4.1 Ultragenyx Pharmaceutical Inc. Corporate Summary
  7.4.2 Ultragenyx Pharmaceutical Inc. Business Overview
  7.4.3 Ultragenyx Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Major Product Offerings
  7.4.4 Ultragenyx Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in Global (2016-2021)
  7.4.5 Ultragenyx Pharmaceutical Inc. Key News
7.5 Janssen Pharmaceuticals Inc.
  7.5.1 Janssen Pharmaceuticals Inc. Corporate Summary
  7.5.2 Janssen Pharmaceuticals Inc. Business Overview
  7.5.3 Janssen Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Major Product Offerings
  7.5.4 Janssen Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in Global (2016-2021)
  7.5.5 Janssen Pharmaceuticals Inc. Key News
7.6 Sigma-Tau Pharmaceuticals Inc.
  7.6.1 Sigma-Tau Pharmaceuticals Inc. Corporate Summary
  7.6.2 Sigma-Tau Pharmaceuticals Inc. Business Overview
  7.6.3 Sigma-Tau Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Major Product Offerings
  7.6.4 Sigma-Tau Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in Global (2016-2021)
  7.6.5 Sigma-Tau Pharmaceuticals Inc. Key News
7.7 AbbVie Inc.
  7.7.1 AbbVie Inc. Corporate Summary
  7.7.2 AbbVie Inc. Business Overview
  7.7.3 AbbVie Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Major Product Offerings
  7.4.4 AbbVie Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in Global (2016-2021)
  7.7.5 AbbVie Inc. Key News
7.8 Sanofi SA
  7.8.1 Sanofi SA Corporate Summary
  7.8.2 Sanofi SA Business Overview
  7.8.3 Sanofi SA Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Major Product Offerings
  7.8.4 Sanofi SA Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in Global (2016-2021)
  7.8.5 Sanofi SA Key News
7.9 Shire PLC
  7.9.1 Shire PLC Corporate Summary
  7.9.2 Shire PLC Business Overview
  7.9.3 Shire PLC Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Major Product Offerings
  7.9.4 Shire PLC Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in Global (2016-2021)
  7.9.5 Shire PLC Key News
7.10 Merck KGaA
  7.10.1 Merck KGaA Corporate Summary
  7.10.2 Merck KGaA Business Overview
  7.10.3 Merck KGaA Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Major Product Offerings
  7.10.4 Merck KGaA Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in Global (2016-2021)
  7.10.5 Merck KGaA Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Opportunities & Trends in Global Market
Table 2. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Drivers in Global Market
Table 3. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Restraints in Global Market
Table 4. Key Players of Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) in Global Market
Table 5. Top Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Share by Companies, 2016-2021
Table 8. Global Companies Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product Type
Table 9. List of Global Tier 1 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2022-2027
Table 30. Pfizer Inc. Corporate Summary
Table 31. Pfizer Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product Offerings
Table 32. Pfizer Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue (US$, Mn), (2016-2021)
Table 33. Alexion Pharmaceuticals Inc. Corporate Summary
Table 34. Alexion Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product Offerings
Table 35. Alexion Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue (US$, Mn), (2016-2021)
Table 36. BioMarin Pharmaceutical Inc. Corporate Summary
Table 37. BioMarin Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product Offerings
Table 38. BioMarin Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue (US$, Mn), (2016-2021)
Table 39. Ultragenyx Pharmaceutical Inc. Corporate Summary
Table 40. Ultragenyx Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product Offerings
Table 41. Ultragenyx Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue (US$, Mn), (2016-2021)
Table 42. Janssen Pharmaceuticals Inc. Corporate Summary
Table 43. Janssen Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product Offerings
Table 44. Janssen Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue (US$, Mn), (2016-2021)
Table 45. Sigma-Tau Pharmaceuticals Inc. Corporate Summary
Table 46. Sigma-Tau Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product Offerings
Table 47. Sigma-Tau Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue (US$, Mn), (2016-2021)
Table 48. AbbVie Inc. Corporate Summary
Table 49. AbbVie Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product Offerings
Table 50. AbbVie Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue (US$, Mn), (2016-2021)
Table 51. Sanofi SA Corporate Summary
Table 52. Sanofi SA Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product Offerings
Table 53. Sanofi SA Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue (US$, Mn), (2016-2021)
Table 54. Shire PLC Corporate Summary
Table 55. Shire PLC Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product Offerings
Table 56. Shire PLC Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue (US$, Mn), (2016-2021)
Table 57. Merck KGaA Corporate Summary
Table 58. Merck KGaA Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Product Offerings
Table 59. Merck KGaA Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Segment by Type
Figure 2. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Segment by Application
Figure 3. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue in 2020
Figure 8. By Type - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share, 2016-2027
Figure 9. By Application - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share, 2016-2027
Figure 10. By Region - Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share, 2016-2027
Figure 11. By Country - North America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share, 2016-2027
Figure 12. US Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share, 2016-2027
Figure 16. Germany Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 17. France Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share, 2016-2027
Figure 24. China Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 28. India Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share, 2016-2027
Figure 30. Brazil Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Market Share, 2016-2027
Figure 33. Turkey Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue, (US$, Mn), 2016-2027
Figure 37. Pfizer Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Alexion Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. BioMarin Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Ultragenyx Pharmaceutical Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Janssen Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Sigma-Tau Pharmaceuticals Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. AbbVie Inc. Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Sanofi SA Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Shire PLC Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications